Bill Wilson, MD: GIPs and GLP-1s Are Transforming Metabolic Health and CARB Syndrome Treatment @Emerypharma
Bill Wilson, MD: GIPs and GLP-1s Are Transforming Metabolic Health and CARB Syndrome Treatment  @Emerypharma
Uploaded April 2025 | Updated September 2026, 2 weeks ago
Dear Subscriber,
Thank you for watching our channel. In this series of shorts, we've selected some key soundbites from Professor Robert Lustig's convdersation with Neeku Mahdavian of Emery Pharma.
youtu.be/Nbmqo-HNHC4
In the podcast hosted by Emery Pharma, Dr. Robert Lustig discusses the dangers of ultra-processed foods, arguing that they are not true food but toxins. He emphasizes that calories from different sources are not equivalent, explaining that the body's response to calories varies depending on the food's composition, such as fiber, protein, fats, and sugars. Lustig criticizes the focus on calorie counting, especially concerning sugary drinks, and explains how fructose, unlike glucose, is particularly harmful due to its metabolism in the liver, leading to fat production and mitochondrial dysfunction. He highlights the importance of whole foods and the negative impact of high fructose corn syrup and other sweeteners on health, particularly in causing obesity and other metabolic diseases. Lustig also stresses that while exercise is beneficial, it cannot fully counteract the negative effects of a poor diet rich in ultra-processed foods. The discussion concludes with a call to avoid ultra-processed foods and focus on a diet consisting of real, whole foods for better health and longevity.
we also recommend watching the entire collection of Professor Lustig presentation here:
youtube.com/playlist?list=PLlTSLi3qD78edU0aWyV8x9yLMIS-FC2fv


About Emery Pharma:
Emery Pharma is deeply committed to advancing public health and exclusively focuses on projects that enhance the well-being of both individuals and the environment. As a comprehensive contract research laboratory, Emery Pharma provides extensive support across the entire spectrum of pharmaceutical development, covering small molecule drugs, biologics, biosimilars, gene therapy, botanicals, and more.

Emery Pharma's array of premium services includes analytical and bioanalytical solutions, microbiology and cell biology services, drug and impurity characterization, and comprehensive R&D with cGMP/GLP support. The Emery Pharma team excels in customizing innovative solutions tailored to the unique requirements of each client. They seamlessly oversee the entire process, from initial drug discovery to thorough data analysis and insights generation. Their expertise allows them to tackle scientific challenges proactively, ensuring clients avoid unnecessary setbacks.

Emery Pharma's accomplished chemists and biologists harness state-of-the-art technology, encompassing cutting-edge tools such as high-resolution mass spectrometry (Orbitrap), triple quad LC-MS/MS, GC-MS, preparative HPLC, and 400 MHz multinuclear NMR.

For further details, please don't hesitate to reach out to Emery Pharma at info@emerypharma.com or explore their website at:
emerypharma.com
Bill Wilson, MD: GIPs and GLP-1s Are Transforming Metabolic Health and CARB Syndrome TreatmentRobert Lustig: Eliminating Sugar, Not Calories, Reverses Fatty Liver and Restores Metabolic HealthRobert Lustig: Why Children Are Developing Type 2 Diabetes Without Obesity? Puzzling !Bill Wilson, MD: GLP-1 Drugs—Revolutionary, Low-Toxicity “Miracle” Treatment for Metabolism #glp1Robert Lustig, MD: Why Methionine and Choline Deficiency Can Trigger Fatty Liver Without ObesityRobert Lustig: Why the Little Women of Loja Prove Obesity Isn’t Always the Root of Chronic DiseaseRobert Lustig: Key Biomarkers, fasting insulin, Uric Acid and ALT Signal Metabolic Syndrome RiskRobert Lustig MD: Why BMI Misleads—It’s Insulin Resistance That Truly Predicts Metabolic HealthBill Wilson, MD: GLP-1 Agonists Show Promise in Reversing CARB Syndrome—A Breakthrough in Treatment!Robert Lustig: It’s Not the Fat You See—It’s the Fat You Don’t See that Matter Most !!Bill Wilson, MD: GLP-1s Are Miracle Drugs That Could Reverse Insulin Resistance & Metabolic DiseaseRobert Lustig, MD: Lose Just 5% Weight & Shed Toxic Visceral Fat for Metabolic Health Boost!
Emery Pharma |

Bill Wilson, MD: GIPs and GLP-1s Are Transforming Metabolic Health and CARB Syndrome Treatment

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER